Ramiro Ribeiro, MD, PhD

Chief Medical Officer

Ramiro Ribeiro, MD, PhD is a retinal specialist and the Chief Medical Officer of EyePoint Pharmaceuticals. He leads the Clinical Development, Clinical Operations and Medical Safety teams at Eyepoint with a profound commitment in innovation to advance patient care and medical excellence. With over 15 years of experience encompassing clinical practice, academy and pharmaceutical industry, Dr. Ribeiro brings a wealth of expertise to his leadership position. Before joining EyePoint, Dr. Ribeiro served as the Head of Clinical Development at Apellis Pharmaceutical, where he served as the clinical lead for the sucessful approval of Syfovre, the first ever therapy for Geographic Atrophy secondary to AMD. Previously, he held roles at Ophthotech (now Iveric Bio), Alcon Pharmaceutical and Acucela, where he made significant contributions to the retina field. Dr. Ribeiro holds a M.D. from Pontifical University of Parana, a Ph.D. from Federal University of Sao Paulo and was a research fellow at University of Southern California.